Search

everythinglearnresearchcommunity

for

Search:↓

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Permanent hair dye mixtures can irritate and damage the skin.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

CD2 might be a new treatment target for patchy alopecia areata.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Exosomes could be effective for improving skin health and treating skin diseases.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.